The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
Labroots and the Cell & Gene Therapy planning committee are thrilled to announce the debut of the Cell & Gene Therapy Virtual Event Series, premiering exclusively online October 16th, 2024. Join us as we bring together speakers from industry and academia to delve into the pivotal challenges, emerging opportunities, and recent triumphs within the dynamic landscape of Cell & Gene Therapy.
This inaugural 2024 Cell & Gene Therapy Virtual Event stands as a premier space for experts to illuminate the latest strides in medical innovation harnessing genetic and cellular methodologies. Expect in-depth discussions covering revolutionary technologies used for precision genome editing, advancements and innovations in immune effector cell therapies, and the growing role or AI in gene therapy. The event will comprehensively explore diverse disease applications, ranging from oncology to genetic disorders, while also addressing pertinent ethical and societal considerations.
Prepare to immerse yourself in a knowledge-rich environment tailored to professionals and enthusiasts alike.
Secure your spot now for the 2024 Cell & Gene Therapy Virtual Event.
Emerging Therapeutic Modalities: Current Practices, Challenges, Novel Solutions
Revolutionary Technologies: Present and Future of Cell and Gene Therapy
Development of Cell and Gene Therapies to Treat, Prevent, and Potentially Cure Diseases
Bioanalysis of Novel Therapeutic Modalities: Advancements and Challenges
Regulatory Aspects of Cell and Gene Therapies
This event is accepting abstract submissions for on-demand educational talks on relevant topics. For more information, please contact our Senior Scientific Editor, Sarah Hoffman (sarah.hoffman@labroots.com).
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2024 Cell & Gene Therapy Virtual Event Series. Submission is free. Submit your abstract here.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 1 year from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global drug discovery community with a high degree of interaction through live-streaming video and chat sessions.
Connect with us!
When you attend the event remember to use the hashtag #LRCellandGene to follow the conversation and connect with other members of the global Cell & Gene Therapy community! Follow @Genetics_LR on Twitter and Genetics & Genomics on Facebook to connect with our specialist Cell & Gene Therapy writers and stay up to date with the latest Trending News in Cell & Gene Therapy.
You can now also join our Genetics & Genomics professional networking group on LinkedIn!
Labroots is a proud partner of Chati, a virtual event platform that allows for the hosting of engaging and interactive virtual and hybrid events, catering to businesses of any vertical or size.
Continuing Education
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.
Postdoctoral Scholar, The University of Iowa
Postdoctoral Associate
Principal Investigator - Bioprocess Systems Engineering Group
Professor of Biomolecular Engineering
Chief Diagnostic Officer Everly Health
CEO | CTO | Founder
SPARTA Biodiscovery
Sr. Science & Technology Advisor
Bioassay Development Lead
Research Assistant Professor of Medicine (Cardiovascular Medicine)
Sales Manager, BioEcho Life Sciences
Dorottya earned her MD and PhD in clinical medicine from Semmelweis University of Medicine in Hungary. Holding postdoctoral fellowships at Baylor College of Medicine/Texas Children's Hospital and Columbia University, she has 10+ years of experience in translational medicine ...
See moreTatjana is an immunologist with more than two decades of experience working at biotech and pharma companies from start-ups to large global corporations ( Pfizer,Inc. being the latest), contributing significantly to team efforts and successes of more than thirty early and clinical ...
See moreMolly McGinniss, MS, CGC, is Senior Director of Client and Partner Relations for Population Genomics at Genome Medical, a digital health company and specialty medical group focused on genetics and genomics. Through the Genome Medical Precision Insights team, she provides ...
See moreSteering the diagnostic frontier, my current role as Chief Diagnostic Officer builds on a robust foundation in translational science and organizational change management. With a commitment to innovation, my teams have advanced the development of diagnostic tests, integrating data ...
See moreJessica received her PhD at the University of California, Berkeley. She has spent her 20-year career in biotech as a scientist and marketer of biomarker tools for both research and clinical use. She enjoys the process of building an in-depth understanding of needs with respect to ...
See more